南财智讯8月26日电，维远股份发布2025年半年度报告，报告期实现营业收入46.01亿元，同比增长 1.82%；归属上市公司股东的净利润-1.68亿元，同比下降568.79%；扣除非经常性损益后的归属于上市 公司股东的净利润-1.62亿元，同比下降643.47%；基本每股收益-0.31元。 ...

证券代码：600955 证券简称：维远股份 公告编号：2025-024 利华益维远化学股份有限公司 2025年半年度主要经营数据公告 本公司及董事会全体成员保证本公告内容不存在虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 根据上海证券交易所《上市公司自律监管指引第 3 号行业信息披露： 第十三号——化工》的相关要求，利华益维远化学股份有限公司（以下简 称"公司"）现将 2025 年上半年主要经营数据披露如下： 注：1、酚酮相关产品主要包括：苯酚、丙酮、异丙醇、双酚 A。 2、新能源新材料相关产品主要包括：碳酸二甲酯、碳酸丙烯酯、聚碳酸酯、聚碳酸酯改 性合金等产品。 3、专用化学品主要包括：丙烯、环氧丙烷、双氧水、碳四、丙二醇等。 4、工业气体主要包括：氢气、氮气、氧气、仪表空气、二氧化碳、液氧、液氮、液氩等。 二、主要产品及原材料的价格变动情况 （一）主要产品的价格变动情况（不含税） 1 一、主要产品的产量、销量及收入实现情况 主要产品 2025年上半年产量 （吨） 2025 年上半年外销量 （吨） 2025 年上半年销售金 额（不含税）（万元） 酚酮相关产品 6 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 利华益维远化学股份有限公司（以下简称"公司"）于 2025 年 8 月 26 日召开第三届董事会第九次会议，审议通过了《关于取消公司监事会并 修订<公司章程>的议案》《关于修订公司部分治理制度的议案》等议案， 具体情况如下： 证券代码：600955 证券简称：维远股份 公告编号：2025-022 利华益维远化学股份有限公司 关于取消监事会并修订《公司章程》及部分 治理制度的公告 一、修订《公司章程》及取消监事会的情况 根据《中华人民共和国公司法》的相关规定，结合公司实际情况，公 司将不再设置监事会，监事会的职权由董事会审计委员会行使，《利华益 维远化学股份有限公司监事会议事规则》等监事会相关制度相应废止，同 时对《公司章程》及部分治理制度作出相应修订，修订的《公司章程》具 | 条款 | 原章程条款内容 | 修订后章程条款内容 | | --- | --- | --- | | 第一条 | 原章程第一条为维护利华益维远 | 为维护利华益维远化学股份有限 | | | 化学股份有限公 ...

Group 1 - The company reported a revenue of 4.601 billion yuan for the first half of 2025, representing a year-on-year increase of 1.82% [1] - The net profit attributable to shareholders of the listed company was -168 million yuan, a year-on-year decrease of 568.79% [1] - The basic earnings per share were -0.31 yuan, reflecting a year-on-year decrease of 616.67% [1]

证券日报网讯8月20日晚间，维远股份（600955）发布公告称，公司计划于2025年8月27日(星期三)9： 00-10：00举行2025年半年度业绩说明会。 ...

证券代码：600955 证券简称：维远股份 公告编号：2025-018 利华益维远化学股份有限公司 2025 年半年度业绩说明会预告公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 利华益维远化学股份有限公司（以下简称"公司"）已于 2025 年 07 月 12 日披露公司 2025 年半年度业绩预告并将于 2025 年 08 月 27 日发布公 司 2025 年半年度报告，为便于广大投资者更全面深入地了解公司 2025 年 半年度经营成果、财务状况，公司计划于 2025 年 08 月 27 日（星期三） 9:00-10:00 举行 2025 年半年度业绩说明会，就投资者关心的问题进行交 流。 会议召开时间：2025 年 08 月 27 日（星期三）9:00-10:00 会议召开地点：上海证券交易所上证路演中心（网址： http://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2025 年 08 月 21 日（星期四）至 08 月 26 日（星期二）1 ...

Core Viewpoint - Viyuan Co., Ltd. (维远股份) has announced a significant decline in expected net profit for the first half of 2025, projecting a loss between 175 million to 165 million yuan, compared to a profit of 35.73 million yuan in the same period last year [1] Financial Performance Summary - In 2024, Viyuan Co., Ltd. reported operating revenue of 9.52 billion yuan, representing a year-on-year increase of 35.06% [3] - The net profit attributable to shareholders decreased by 42.62% to 565.89 million yuan, down from 98.62 million yuan in 2023 [3] - The net profit after deducting non-recurring gains and losses was 453.11 million yuan, a decline of 36.85% compared to 71.75 million yuan in the previous year [3] - The net cash flow from operating activities increased by 49.52% to 918.53 million yuan, compared to 613.86 million yuan in 2023 [3] Initial Public Offering (IPO) Details - Viyuan Co., Ltd. raised a total of 4.065 billion yuan through its IPO, with a net amount of 3.88 billion yuan after deducting issuance costs [4] - The final net fundraising amount exceeded the original plan by 2 billion yuan, and the number of investment projects increased by one [4] - The IPO was conducted on September 15, 2021, with an issuance price of 29.56 yuan per share, and the underwriting was managed by CITIC Securities [4]

Group 1 - The company expects a net profit attributable to shareholders for the first half of 2025 to be between -175 million and -165 million yuan, indicating a loss compared to the same period last year [1][2] - The expected net profit attributable to shareholders after deducting non-recurring gains and losses is projected to be between -170 million and -160 million yuan, also reflecting a loss compared to the previous year [1][2] - The previous year's net profit attributable to shareholders was 35.73 million yuan, with a net profit of 29.84 million yuan after deducting non-recurring gains and losses [1] Group 2 - The primary reasons for the expected loss include a decline in product demand and a decrease in sales prices [2] - The company is taking measures to optimize various processes, enhance employee training, improve production efficiency, control costs, and accelerate inventory turnover [2] - Non-operating gains and losses, as well as accounting treatment, are not expected to have a significant impact on the company's anticipated loss [2]

Earnings Forecast and Prior-Year Comparison [H1 2025 Performance Forecast](index=1&type=section&id=%E4%B8%80%E3%80%81%E6%9C%AC%E6%9C%9F%E4%B8%9A%E7%BB%A9%E9%A2%84%E5%91%8A%E6%83%85%E5%86%B5) The company forecasts a shift from profit to a net loss of RMB 165-175 million for H1 2025 Forecasted Performance for H1 2025 | Forecast Item | Forecasted Amount (RMB) | | :--- | :--- | | Net Profit Attributable to Shareholders | -175.00 million to -165.00 million | | Net Profit after Non-Recurring Items | -170.00 million to -160.00 million | - The performance forecast covers the period from January 1, 2025, to June 30, 2025[3](index=3&type=chunk) - The company states that this performance forecast is based on **preliminary data and has not been audited** by a certified public accountant[5](index=5&type=chunk) [Prior-Year Period Performance Review](index=2&type=section&id=%E4%BA%8C%E3%80%81%E4%B8%8A%E5%B9%B4%E5%90%8C%E6%9C%9F%E7%BB%8F%E8%90%A5%E4%B8%9A%E7%BB%A9%E5%92%8C%E8%B4%A2%E5%8A%A1%E7%8A%B6%E5%86%B5) In contrast, the company was profitable in the prior-year period (H1 2024), with a net profit of RMB 35.74 million H1 2024 Performance | Item | H1 2024 Amount (RMB) | | :--- | :--- | | Net Profit Attributable to Shareholders | 35.74 million | | Net Profit after Non-Recurring Items | 29.85 million | | Earnings Per Share (EPS) | 0.06 | Analysis of Reasons for Forecasted Loss [Impact from Core Business Operations](index=2&type=section&id=%EF%BC%88%E4%B8%80%EF%BC%89%E4%B8%BB%E8%90%A5%E4%B8%9A%E5%8A%A1%E5%BD%B1%E5%93%8D) The forecasted loss is primarily due to margin compression from falling product prices outpacing raw material cost declines - The company's **profit margins were squeezed** as the decline in major product prices outpaced the drop in raw material costs[7](index=7&type=chunk) - Increased costs from trial production runs for new projects and equipment maintenance further pressured current period profits[7](index=7&type=chunk) - External factors including international trade policies, geopolitics, and logistics led to **decreased demand and falling sales prices** for some products[7](index=7&type=chunk) - The company is actively responding by optimizing production, strengthening cost controls, and accelerating inventory turnover[7](index=7&type=chunk) [Impact from Non-Operating Items and Accounting](index=2&type=section&id=%EF%BC%88%E4%BA%8C%EF%BC%89%E9%9D%9E%E7%BB%8F%E8%90%A5%E6%80%A7%E6%8D%9F%E7%9B%8A%E7%9A%84%E5%BD%B1%E5%93%8D) Non-recurring items and accounting treatments did not materially impact the forecasted loss, which stems from core operations - Non-recurring gains and losses had **no significant impact** on the company's forecasted loss[7](index=7&type=chunk) - Accounting treatments had **no significant impact** on the company's forecasted loss[8](index=8&type=chunk) Risk Warnings and Other Matters [Risk Warnings and Other Matters](index=3&type=section&id=%E5%9B%9B%E3%80%81%E9%A3%8E%E9%99%A9%E6%8F%90%E7%A4%BA_and_%E4%BA%94%E3%80%81%E5%85%B6%E4%BB%96%E8%AF%B4%E6%98%8E%E4%BA%8B%E9%A1%B9) The company confirms no major uncertainties affecting this forecast but cautions that the data is preliminary - The company confirms there are **no significant uncertainties** that would affect the accuracy of this performance forecast[9](index=9&type=chunk) - Investors are advised that the forecast data is preliminary; **final accurate financial data will be in the official 2025 semi-annual report**[10](index=10&type=chunk)

Core Viewpoint - The global largest phenol and acetone producer, INEOS, plans to permanently shut down its phenol production facility in Gladbeck, Germany, due to high energy costs and punitive carbon tax policies in Europe, which have diminished its competitiveness against imports from China and global oversupply [1][2]. Group 1: Industry Impact - The closure of INEOS's facility, which had an annual production capacity of 650,000 tons of phenol and 400,000 tons of acetone, is indicative of a broader trend of potential shutdowns in the European phenol industry due to energy competitiveness issues [2]. - Domestic phenol prices are currently at historical lows, with the average price in East China at 6,550 CNY/ton as of July 7, 2023, and a projected average of 7,026 CNY/ton for the first half of 2025 [1][2]. - The domestic phenol industry is experiencing a slowdown in production capacity growth, with effective capacity increasing from 3.33 million tons/year in 2021 to 6.57 million tons/year by 2024, but the compound annual growth rate (CAGR) is expected to drop to 3.57% in 2024 [2][3]. Group 2: Domestic Market Dynamics - The apparent consumption of domestic phenol is projected to grow from 3.08 million tons in 2021 to 5.24 million tons in 2024, with a CAGR of 19.37% [3]. - Domestic phenol imports have decreased significantly from 52.23 thousand tons to 24.96 thousand tons, reflecting a CAGR of -21.82%, while exports have also declined from 13.51 thousand tons to 7.91 thousand tons, with a CAGR of -16.35% [3]. - Despite the overall decline in imports and exports, a notable increase in export volume is expected in 2024, with a growth rate of 184.81% [3]. Group 3: Investment Opportunities - The anticipated exit of overseas core phenol production capacity is expected to stimulate domestic production and sales growth, benefiting domestic phenol and acetone producers [4]. - Key domestic companies with phenol production capacities include Weiyuan Co. (440,000 tons/year), Huayi Group (160,000 tons/year), Wanhua Chemical (400,000 tons/year), and Sinochem International (400,000 tons/year) [4]. - Investment focus is recommended on related stocks: Weiyuan Co. (600955.SH), Huayi Group (600623.SH), Sinochem International (600500.SH), and Wanhua Chemical (600309.SH) [4].